1
|
Rodríguez N, Pérez S, Rodríguez JN, Rodríguez J, Esquivel A, Sanabria D, Baena J. Perivascular epithelioid cell tumors (PEComas) of gynecological tract: preoperative diagnostic imaging challenge. Ultrasound Obstet Gynecol 2024; 63:286-288. [PMID: 37902722 DOI: 10.1002/uog.27520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Revised: 10/01/2023] [Accepted: 10/19/2023] [Indexed: 10/31/2023]
Affiliation(s)
- N Rodríguez
- Department of Gynecology, Obstetrics and Human Reproduction, Fundación Santa Fe de Bogotá, Bogotá, Colombia
- School of Medicine, Universidad de los Andes, Bogotá, Colombia
| | - S Pérez
- Department of Gynecology, Obstetrics and Human Reproduction, Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - J N Rodríguez
- Department of Gynecology, Obstetrics and Human Reproduction, Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - J Rodríguez
- Department of Gynecology, Obstetrics and Human Reproduction, Fundación Santa Fe de Bogotá, Bogotá, Colombia
- School of Medicine, Universidad de los Andes, Bogotá, Colombia
| | - A Esquivel
- Department of Gynecology, Obstetrics and Human Reproduction, Fundación Santa Fe de Bogotá, Bogotá, Colombia
- School of Medicine, Universidad de los Andes, Bogotá, Colombia
| | - D Sanabria
- Department of Gynecology, Obstetrics and Human Reproduction, Fundación Santa Fe de Bogotá, Bogotá, Colombia
- School of Medicine, Universidad de los Andes, Bogotá, Colombia
| | - J Baena
- School of Medicine, Universidad de los Andes, Bogotá, Colombia
- Department of Pathology, Fundación Santa Fe de Bogotá, Bogotá, Colombia
| |
Collapse
|
2
|
Garabano G, Pesciallo CA, Rodríguez J, Pérez Alamino L, Tillet F, Del Sel H, Lopreite F. Early appearance of radiolucent lines around total knee arthroplasty in rheumatoid arthritis patients. How does it impact the aseptic failure rate and functional outcomes at 13 years of follow-up? Rev Esp Cir Ortop Traumatol (Engl Ed) 2024:S1888-4415(24)00031-6. [PMID: 38232933 DOI: 10.1016/j.recot.2024.01.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2023] [Accepted: 06/07/2023] [Indexed: 01/19/2024] Open
Abstract
INTRODUCTION Aseptic total knee arthroplasty (TKA) failure has been associated with radiolucent lines. This study aimed to determine the impact of the early appearance of radiolucent lines (linear images of 1, 2, or > 2mm at the cement-bone interface) around the TKA on prosthetic survival and functional outcomes in rheumatoid arthritis (RA) patients during a 2-20 years follow-up. METHODS We retrospectively analyzed a consecutive series of RA patients treated with TKA between 2000 and 2011. We comparatively analyzed patients with and without radiolucent lines around implants. Clinical outcomes were assessed with the knee society score (KSS) collected before surgery, at years 2, 5, and 10, and at the last postoperative follow-up. The knee society roentgenographic evaluation system was used to analyze the impact of radiolucent lines around the implants at 1, 2, 5, and more than ten years of follow-up. The reoperation and prosthetic survival rates were calculated at the end of the follow-up. RESULTS The study series included 72 TKAs with a median follow-up of 13.2 years (range: 4.0-21.0), of which 16 (22.2%) had radiolucent lines. We did not observe aseptic failure, and prosthetic survival at the end of the study was 94.4% (n=68). The KSS improved significantly (p<0.001) between preoperative values at 2, 5, and 10 years and the end of follow-up, with no differences between patients with and without radiolucent lines. CONCLUSIONS Our study demonstrates that the early appearance of radiolucent lines around a TKA in RA patients does not significantly impact prosthetic survival or long-term functional outcomes at 13 years of follow-up.
Collapse
Affiliation(s)
- G Garabano
- Departamento de Traumatología y Ortopedia, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
| | - C A Pesciallo
- Departamento de Traumatología y Ortopedia, Hospital Británico de Buenos Aires, Buenos Aires, Argentina
| | - J Rodríguez
- Departamento de Traumatología y Ortopedia, Hospital Británico de Buenos Aires, Buenos Aires, Argentina
| | - L Pérez Alamino
- Departamento de Traumatología y Ortopedia, Hospital Británico de Buenos Aires, Buenos Aires, Argentina
| | - F Tillet
- Departamento de Traumatología y Ortopedia, Hospital Británico de Buenos Aires, Buenos Aires, Argentina
| | - H Del Sel
- Departamento de Traumatología y Ortopedia, Hospital Británico de Buenos Aires, Buenos Aires, Argentina
| | - F Lopreite
- Departamento de Traumatología y Ortopedia, Hospital Británico de Buenos Aires, Buenos Aires, Argentina
| |
Collapse
|
3
|
Rodríguez-Pedrouzo A, Cisneros-Sureda J, Martínez-Matamoros D, Rey-Varela D, Balado M, Rodríguez J, Lemos ML, Folgueira M, Jiménez C. Detection of Aeromonas salmonicida subsp. salmonicida infection in zebrafish by labelling bacteria with GFP and a fluorescent probe based on the siderophore amonabactin. Microb Pathog 2023; 185:106394. [PMID: 37858632 DOI: 10.1016/j.micpath.2023.106394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2023] [Revised: 10/09/2023] [Accepted: 10/12/2023] [Indexed: 10/21/2023]
Abstract
Zebrafish (Danio rerio) is an excellent model to study bacterial infections in fish and their treatment. We used zebrafish as a model of infection for Aeromonas salmonicida subsp. salmonicida (hereinafter A. salmonicida), the causative agent of fish furunculosis. The infection process of A. salmonicida was studied by immersion of zebrafish larvae in 2 different doses of the bacteria and the fish mortality was monitored for three days. The bacterium caused a high mortality (65 %) in zebrafish larvae only when they were exposed to a high bacterial concentration (107 bacterial cells/mL). To evaluate the use of fluorescence microscopy to follow A. salmonicida infection in vivo, two different fluorescent strains generated by labeling an A. salmonicida strain with either, the green fluorescent protein (GFP), or with a previously reported siderophore amonabactin-sulforhodamine B conjugate (AMB-SRB), were used. The distribution of both labeled bacterial strains in the larvae tissues was evaluated by conventional and confocal fluorescence microscopy. The fluorescent signal showed a greater intensity with the GFP-labeled bacteria, so it could be observed using conventional fluorescence microscopy. Since the AMB-SRB labeled bacteria showed a weaker signal, the larvae were imaged using a laser scanning confocal microscope after 48 h of exposure to the bacteria. Both fluorescent signals were mainly observed in the larvae digestive tract, suggesting that this is the main colonization route of zebrafish for waterborne A. salmonicida. This is the first report of the use of a siderophore-fluorophore conjugate to study a bacterial infection in fish. The use of a siderophore-fluorophore conjugate has the advantage that it is a specific marker and that does not require genetic manipulation of the bacteria.
Collapse
Affiliation(s)
- A Rodríguez-Pedrouzo
- CICA - Centro Interdisciplinar de Química e Bioloxía e Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071, A Coruña, Spain
| | - J Cisneros-Sureda
- CICA - Centro Interdisciplinar de Química e Bioloxía e Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071, A Coruña, Spain
| | - D Martínez-Matamoros
- CICA - Centro Interdisciplinar de Química e Bioloxía e Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071, A Coruña, Spain
| | - D Rey-Varela
- Departamento de Microbiología y Parasitología, Instituto de Acuicultura, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain
| | - M Balado
- Departamento de Microbiología y Parasitología, Instituto de Acuicultura, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain
| | - J Rodríguez
- CICA - Centro Interdisciplinar de Química e Bioloxía e Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071, A Coruña, Spain.
| | - M L Lemos
- Departamento de Microbiología y Parasitología, Instituto de Acuicultura, Universidad de Santiago de Compostela, 15782, Santiago de Compostela, Spain.
| | - M Folgueira
- CICA - Centro Interdisciplinar de Química e Bioloxía e Departamento de Bioloxía, Facultade de Ciencias, Universidade da Coruña, 15071, A Coruña, Spain.
| | - C Jiménez
- CICA - Centro Interdisciplinar de Química e Bioloxía e Departamento de Química, Facultade de Ciencias, Universidade da Coruña, 15071, A Coruña, Spain.
| |
Collapse
|
4
|
Mejia S, Rodríguez J, Ruiz-Patiño A, Archila P, Chamorro D, Arrieta O, Viola L, Ordoñez-Reyes C, Garcia-Robledo J, Sotelo C, Raez L, Samtani S, Recondo G, Martín C, Corrales L, Zatarain-Barrón L, Más L, Ricaurte L, Santoyo N, Cuello M, Jaller E, Vargas C, Carranza H, Otero J, Bermudez M, Gamez T, Cordeiro de Lima V, Malapelle U, Rolfo C, Rosell R, Cardona A. EP16.03-003 Systematic Population-based Identification of NTRK Fusion Genes Among Hispanic Patients with Non-Small Cell Lung Cancer (NSCLC). J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.1063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
5
|
Tabernero E, Rodrigo T, Garros J, Altube L, Garay E, Medina JF, Rodríguez J, Ortiz N, Gullón JA, García-García JM. TB in the elderly: clinical features and outcomes. Int J Tuberc Lung Dis 2022; 26:842-849. [PMID: 35996280 DOI: 10.5588/ijtld.22.0010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND: TB in low-incidence countries is characterised by changes in age distribution towards larger numbers of cases among the elderly.OBJECTIVES: To investigate clinical features and outcomes of TB treatment in older patients and identify predictors of poor outcome.METHODS: Multicentre retrospective study of new TB cases from 53 hospitals included in the registry of the Integrated Tuberculosis Research Programme of the Spanish Society of Pulmonology and Thoracic Surgery (Sociedad Española de Neumología y Cirugía Torácica) between 2006 and 2020.RESULTS: We identified 731 patients aged ≥75 years from a cohort of 7,505 patients with TB. In the elderly, weight loss, disseminated disease and normal X-rays or infiltrates without cavitation were more common. All-cause mortality was 16% (5% of deaths due to TB). The elderly had higher rates of toxicity (6.7%) and hospital admissions (36%). In the multivariate analysis of predictors of TB mortality in ≥75-year-olds, only weight, age and treatment with non-standard regimens remained significant.CONCLUSIONS: TB in older patients needs more attention and remains a challenge because of a lack of specific clinical and radiological features. Standard treatment is effective, although mortality is higher than in young patients. Low weight, non-standard regimens and age are significant predictors of TB mortality.
Collapse
Affiliation(s)
- E Tabernero
- Pneumology Service, Hospital Universitario Cruces, Biocruces-Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain
| | - T Rodrigo
- Integrated Tuberculosis Research Program (Spanish Society of Pneumology and Thoracic Surgery, Bizkaia, Spain
| | - J Garros
- Pneumology Service Hospital de Santa Marina Bilbao, Bizkaia, Spain
| | - L Altube
- Pneumology Service, Hospital de Galdakao-Usansolo, Galdakao, Bizkaia, Spain
| | - E Garay
- Pneumology Service, Hospital Universitario Cruces, Biocruces-Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain
| | - J-F Medina
- Pneumology Service Hospital Universitario Virgen del Rocio, Sevilla, Spain
| | - J Rodríguez
- Hospital del Oriente de Asturias "Francisco Grande Covián, Castañera, Spain
| | - N Ortiz
- Pneumology Service, Hospital Universitario Cruces, Biocruces-Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain
| | - J-A Gullón
- Pneumology Service, Hospital Universitario San Agustin, Aviles, Spain
| | - J-M García-García
- Integrated Tuberculosis Research Program (Spanish Society of Pneumology and Thoracic Surgery, Bizkaia, Spain
| |
Collapse
|
6
|
Chamorro D, Ruiz-Patiño A, Recondo G, Martín C, Raez L, Samtani S, Minata J, Blaquier J, Enrico D, Burotto M, Ordoñez-Reyes C, Garcia-Robledo J, Corrales L, Zatarain-Barrón L, Más L, Sotelo C, Ricaurte L, Santoyo N, Cuello M, Mejia S, Jaller E, Vargas C, Carranza H, Otero J, Rodríguez J, Archila P, Bermudez M, Gamez T, Cordeiro de Lima V, Freitas H, Russo A, Polo C, Malapelle U, de Miguel-Perez D, Rolfo C, Viola L, Rossell R, Arrieta O, Cardona A. EP16.03-002 Mechanisms of Resistance to First-line Osimertinib in Hispanic Patients with EGFR mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP∫). J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.1062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
7
|
Rojas L, Mayorga D, Ruiz-Patiño A, Rodríguez J, Cardona AF, Archila P, Avila J, Bravo M, Ricaurte L, Sotelo C, Arrieta O, Zatarain-Barrón ZL, Carranza H, Otero J, Vargas C, Barrón F, Corrales L, Martín C, Recondo G, Pino LE, Bermudez MA, Gamez T, Ordoñez-Reyes C, García-Robledo JE, de Lima VC, Freitas H, Santoyo N, Malapelle U, Russo A, Rolfo C, Rosell R. Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors. ESMO Open 2022; 7:100500. [PMID: 35753086 PMCID: PMC9434139 DOI: 10.1016/j.esmoop.2022.100500] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Revised: 03/27/2022] [Accepted: 04/19/2022] [Indexed: 11/03/2022] Open
Abstract
BACKGROUND Human papilloma virus (HPV) has been associated with the development and modulation of response in a series of neoplasms. In the case of lung adenocarcinoma, its role in etiology and pathogenesis is still controversial. Considering that this infection brings foreign epitopes, it could be of prognostic significance in patients with lung adenocarcinoma treated with immunotherapy. METHODS In a retrospective cohort study we evaluated the presence of HPV genomic material in lung adenocarcinoma primary lesions with the INNO-LiPA platform. Viral replication was also evaluated by detecting the presence of oncoprotein E6/E7 messenger RNA (mRNA) by quantitative RT-PCR. To confirm possible hypotheses regarding viral oncogenesis, vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1 (HIF1) were evaluated with stromal fibrosis and immunoscore. RESULTS A total of 133 patients were included in the analysis, of whom 34 tested positive for HPV, reaching an estimated prevalence of 25.6% [95% confidence interval (CI) 18.2% to 32.9%]. E6/7 mRNA was identified in 28 out of the 34 previously positive cases (82.3%). In immune checkpoint inhibitor (ICI)-treated patients, the median overall survival reached 22.3 months [95% CI 19.4 months- not reached (NR)] for HPV-negative and was not reached in HPV-positive (HPV+) ones (95% CI 27.7-NR; P = 0.008). With regard to progression-free survival, HPV- patients reached a median of 9.2 months (95% CI 7.9-11.2 months) compared to 14.3 months (95% CI 13.8-16.4 months) when HPV was positive (P = 0.001). The overall response rate for HPV+ patients yielded 82.4% compared to 47.1% in negative ones. No differences regarding programmed death-ligand 1, VEGF, HIF1, stromal fibrosis, or immunoscore were identified. CONCLUSIONS In patients with HPV+ lung adenocarcinoma, a significant benefit in overall response and survival outcomes is observed.
Collapse
Affiliation(s)
- L Rojas
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Oncology Department, Clinica Colsanitas, Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia; Clinical and Traslational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia
| | - D Mayorga
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia
| | - A Ruiz-Patiño
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia
| | - J Rodríguez
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia
| | - A F Cardona
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Oncology Department, Clinica Colsanitas, Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia; Clinical and Traslational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia.
| | - P Archila
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia
| | - J Avila
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia
| | - M Bravo
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia
| | - L Ricaurte
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia; Pathology Department, Mayo Clinic, Rochester, USA
| | - C Sotelo
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia
| | - O Arrieta
- Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), México City, México
| | - Z L Zatarain-Barrón
- Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), México City, México
| | - H Carranza
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Oncology Department, Clinica Colsanitas, Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia; Clinical and Traslational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia
| | - J Otero
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Oncology Department, Clinica Colsanitas, Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia; Clinical and Traslational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia
| | - C Vargas
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Oncology Department, Clinica Colsanitas, Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia; Clinical and Traslational Oncology Group, Institute of Oncology, Clínica del Country, Bogotá, Colombia
| | - F Barrón
- Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), México City, México
| | - L Corrales
- Medical Oncology Department, Centro de Investigación y Manejo del Cáncer - CIMCA, San José, Costa Rica
| | - C Martín
- Thoracic Oncology Unit, Alexander Fleming Institute, Buenos Aires, Argentina
| | - G Recondo
- Thoracic Oncology Unit, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina
| | - L E Pino
- Clinical Oncology Department, Institute of Oncology, Fundación Santa Fe de Bogotá, Bogotá, Colombia
| | - M A Bermudez
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia
| | - T Gamez
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia
| | - C Ordoñez-Reyes
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia
| | | | - V C de Lima
- Medical Oncology Department, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil; Oncologia D'Or, São Paulo, Brazil
| | - H Freitas
- Medical Oncology Department, Thoracic Oncology Section, A. C. Camargo Cancer Center, São Paulo, Brazil
| | - N Santoyo
- Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia; Molecular Oncology and Biology Systems Research Group (FOX-G), Universidad el Bosque, Bogotá, Colombia
| | - U Malapelle
- Department of Public Health, University of Naples Federico II, Naples, Italy
| | - A Russo
- Medical Oncology Unit, A.O. Papardo, Messina, Italy
| | - C Rolfo
- Center for Thoracic Oncology, Tisch Cancer Center, Mount Sinai Hospital System & Icahn School of Medicine, Mount Sinai, New York, USA
| | - R Rosell
- Coyote Research Group, Pangaea Oncology, Laboratory of Molecular Biology, Quiron-Dexeus University Institute, Barcelona, Spain; Institut d'Investigació en Ciències Germans Trias i Pujol, Badalona, Spain; Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain
| | | |
Collapse
|
8
|
Novoa Del Valle C, Taboada M, Rodríguez J, Quevedo JE. Anaesthetic management in a patient with arthrogryposis multiplex congenita. Rev Esp Anestesiol Reanim (Engl Ed) 2022; 69:54-55. [PMID: 35031263 DOI: 10.1016/j.redare.2020.12.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/13/2020] [Accepted: 12/07/2020] [Indexed: 06/14/2023]
Affiliation(s)
- C Novoa Del Valle
- Departamento de Anestesiología y Reanimación, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
| | - M Taboada
- Departamento de Anestesiología y Reanimación, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain
| | - J Rodríguez
- Departamento de Anestesiología y Reanimación, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain
| | - J E Quevedo
- Departamento de Anestesiología y Reanimación, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain
| |
Collapse
|
9
|
Cabeza-Gil I, Calvo B, Rico A, Reinhards-Hervás C, Rodríguez J. Mechanical characterisation of hydrophobic and hydrophilic acrylates used in intraocular lenses through depth sensing indentation. J Mech Behav Biomed Mater 2021; 126:104997. [PMID: 34848137 DOI: 10.1016/j.jmbbm.2021.104997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2021] [Revised: 11/08/2021] [Accepted: 11/23/2021] [Indexed: 10/19/2022]
Abstract
In this work, the mechanical behaviour of hydrophilic and hydrophobic acrylates has been characterised by depth sensing indentation. Time-dependent behaviour has been studied using load-relaxation tests. Experiments have been simulated with a finite element software using a visco-hyperelastic material model. The parameters of this model have been determined using deep learning techniques. The developed material models have been used to mechanically simulate a standard compression test of a prototype intraocular lens.
Collapse
Affiliation(s)
- I Cabeza-Gil
- Aragon Institute of Engineering Research (i3A), University of Zaragoza, Spain
| | - B Calvo
- Aragon Institute of Engineering Research (i3A), University of Zaragoza, Spain; Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN), Spain
| | - A Rico
- Durability and Mechanical Integrity of Structural Materials, Rey Juan Carlos University, Spain
| | - C Reinhards-Hervás
- Durability and Mechanical Integrity of Structural Materials, Rey Juan Carlos University, Spain
| | - J Rodríguez
- Durability and Mechanical Integrity of Structural Materials, Rey Juan Carlos University, Spain.
| |
Collapse
|
10
|
Vidal-Cordasco M, Rodríguez J, Prado-Nóvoa O, Zorrilla-Revilla G, Mateos A. Locomotor Economy and Foraging Ecology in Hominins. Journal of Anthropological Research 2021. [DOI: 10.1086/715402] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
11
|
Rodríguez J, Isern J, Pons N, Carmona A, Vallejo E, Cassadó J, De Marcos JA, Paraira M, Giménez N, Pessarrodona A. Pregnancy outcomes after ultrasound-guided high-intensity focused ultrasound (USgHIFU) for conservative treatment of uterine fibroids: experience of a single institution. Int J Hyperthermia 2021; 38:9-17. [PMID: 34420443 DOI: 10.1080/02656736.2021.1908633] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
OBJECTIVE To assess the impact of ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for uterine fibroids on fertility. MATERIAL AND METHODS A retrospective observational study was conducted of 560 reproductive-age women with symptomatic uterine fibroids who underwent USgHIFU therapy at Mútua Terrassa University Hospital, Spain, between February 2008 and February 2018. We analyzed pregnancy outcomes including time to conception, pregnancy approach, gestational age, delivery mode, neonatal outcomes and complications during pregnancy and delivery. RESULTS After USgHIFU treatment, 71 pregnancies were obtained in 55 patients. Of these, 58 (82%) cases were natural pregnancies and 13 (18%) were in vitro fertilization (IVF) pregnancies. The median time to conception was 12 (range 1-72) months. There were 43 (61%) successful deliveries, including a twin gestation, 22 (31%) spontaneous abortions and 6 (8%) therapeutic abortions. The rate of full-term deliveries was 91% (39/43) and the remaining 9% (4/43) were preterm deliveries. Of the 44 live births, 25 (57%) were born vaginally and 19 (43%) by cesarean section. The complications reported included 3 women with retained placenta (7%), 2 with placenta previa (5%) and 1 with severe preeclampsia (2%). The mean birth weight was 3.1 (range: 1.4-4.3) kg, and except for a baby born with a tetralogy of Fallot, all newborns developed well without complications during postpartum and breastfeeding. CONCLUSION Patients undergoing USgHIFU treatment of uterine fibroids can achieve full-term pregnancies with few intrapartum or postpartum complications. More studies are required to compare fertility and perinatal outcomes between patients who underwent or not USgHIFU.
Collapse
Affiliation(s)
- J Rodríguez
- HIFU Unit, Hospital Universitari Mútua Terrassa, Barcelona, Spain.,Department of Obstetrics and Gynecology, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - J Isern
- HIFU Unit, Hospital Universitari Mútua Terrassa, Barcelona, Spain.,Department of Obstetrics and Gynecology, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - N Pons
- HIFU Unit, Hospital Universitari Mútua Terrassa, Barcelona, Spain.,Department of Obstetrics and Gynecology, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - A Carmona
- HIFU Unit, Hospital Universitari Mútua Terrassa, Barcelona, Spain.,Department of Obstetrics and Gynecology, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - E Vallejo
- Department of Obstetrics and Gynecology, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - J Cassadó
- Department of Obstetrics and Gynecology, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - J A De Marcos
- Department of Radiology, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - M Paraira
- Department of Radiology, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| | - N Giménez
- Research Unit, Research Foundation Mútua Terrassa, Universitat de Barcelona, Barcelona, Spain
| | - A Pessarrodona
- HIFU Unit, Hospital Universitari Mútua Terrassa, Barcelona, Spain.,Department of Obstetrics and Gynecology, Hospital Universitari Mútua Terrassa, Barcelona, Spain
| |
Collapse
|
12
|
Ramirez Daffos P, Jiménez E, Bolaños Naranjo M, González-Astorga B, Rubiales S, Ceballos Barbancho E, Rodríguez J, Reina Zoilo J. P-60 Doxycycline as preventive treatment of skin toxicity in patients with metastatic colorectal cancer treated with an anti-EGFR and chemotherapy. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.05.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
13
|
Novoa Del Valle C, Taboada M, Rodríguez J, Quevedo JE. Anaesthetic management in a patient with arthrogryposis multiplex congenita. Rev Esp Anestesiol Reanim (Engl Ed) 2021; 69:S0034-9356(21)00052-9. [PMID: 34148695 DOI: 10.1016/j.redar.2020.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/13/2020] [Revised: 12/01/2020] [Accepted: 12/07/2020] [Indexed: 06/12/2023]
Affiliation(s)
- C Novoa Del Valle
- Departamento de Anestesiología y Reanimación, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, España.
| | - M Taboada
- Departamento de Anestesiología y Reanimación, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - J Rodríguez
- Departamento de Anestesiología y Reanimación, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, España
| | - J E Quevedo
- Departamento de Anestesiología y Reanimación, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, España
| |
Collapse
|
14
|
García-Herranz N, Rodríguez J, Jiménez-Carrascosa A, Cabellos O. DIAGNOSIS OF THE UNRESOLVED DOMAIN TREATMENT IN MONTE CARLO TRANSPORT CALCULATIONS THROUGH THE IDENTIFICATION AND MODELLING OF CRITICALITY SAFETY EXPERIMENTS. EPJ Web Conf 2021. [DOI: 10.1051/epjconf/202124710003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Monte Carlo neutron transport codes can be used for high-fidelity predictions of the performance of nuclear systems. However, validation against experiments is required in order to establish the credibility in the results and identify the inaccuracies due to the used calculation scheme and associated databases. The International Handbook of Evaluated Criticality Safety Benchmark Experiments (ICSBEP) contains criticality safety benchmarks derived from experiments that have been performed at various nuclear critical facilities around the world and are very valuable for validation purposes.
The main objective of this work is the identification and modelling of experimental benchmarks included at ICSBEP in support of the validation of Monte Carlo neutron transport calculations when applied to fast systems, and in particular, KENO-VI and associated AMPX-formatted continuous-energy libraries from SCALE package. In such systems, the predicted k-eff values can be very sensitive to the treatment of nuclear data in the Unresolved Resonance Region (URR). Consequently, benchmarks with intermediate and fast spectra are identified and modelled with KENO-VI. Then, calculated results with and without probability tables in the URR are compared with each other in order to identify the most sensitive configurations to the URR. As a result of the proposed study, recommendations are given about the benchmarks that should be modelled and analysed to qualify the processed continuous-energy libraries before their use in Monte Carlo transport codes for practical fast reactor applications.
Collapse
|
15
|
Candel FJ, Barreiro P, San Román J, Abanades JC, Barba R, Barberán J, Bibiano C, Canora J, Cantón R, Calvo C, Carretero M, Cava F, Delgado R, García-Rodríguez J, González Del Castillo J, González de Villaumbrosia C, Hernández M, Losa JE, Martínez-Peromingo FJ, Molero JM, Muñoz P, Onecha E, Onoda M, Rodríguez J, Sánchez-Celaya M, Serra JA, Zapatero A. Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings. Rev Esp Quimioter 2020; 33:466-484. [PMID: 33070578 PMCID: PMC7712344 DOI: 10.37201/req/120.2020] [Citation(s) in RCA: 38] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/13/2020] [Accepted: 10/14/2020] [Indexed: 01/10/2023]
Abstract
The high transmissibility of SARS-CoV-2 before and shortly after the onset of symptoms suggests that only diagnosing and isolating symptomatic patients may not be sufficient to interrupt the spread of infection; therefore, public health measures such as personal distancing are also necessary. Additionally, it will be important to detect the newly infected individuals who remain asymptomatic, which may account for 50% or more of the cases. Molecular techniques are the "gold standard" for the diagnosis of SARS-CoV-2 infection. However, the massive use of these techniques has generated some problems. On the one hand, the scarcity of resources (analyzers, fungibles and reagents), and on the other the delay in the notification of results. These two facts translate into a lag in the application of isolation measures among cases and contacts, which favors the spread of the infection. Antigen detection tests are also direct diagnostic methods, with the advantage of obtaining the result in a few minutes and at the very "pointof-care". Furthermore, the simplicity and low cost of these tests allow them to be repeated on successive days in certain clinical settings. The sensitivity of antigen tests is generally lower than that of nucleic acid tests, although their specificity is comparable. Antigenic tests have been shown to be more valid in the days around the onset of symptoms, when the viral load in the nasopharynx is higher. Having a rapid and real-time viral detection assay such as the antigen test has been shown to be more useful to control the spread of the infection than more sensitive tests, but with greater cost and response time, such as in case of molecular tests. The main health institutions such as the WHO, the CDC and the Ministry of Health of the Government of Spain propose the use of antigenic tests in a wide variety of strategies to respond to the pandemic. This document aims to support physicians involved in the care of patients with suspected SC2 infection, in the context of a growing incidence in Spain since September 2020, which already represents the second pandemic wave of COVID-19.
Collapse
Affiliation(s)
- F J Candel
- Dr. Francisco Javier Candel. Enfermedades Infecciosas y Microbiología Clínica. Hospital Clínico San Carlos. Institutos IdISSC e IML. Profesor Asociado. Facultad de Medicina. UCM. Madrid. Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Mendieta O, Castro L, Rodríguez J, Escalante H. Management and valorization of waste from a non-centrifugal cane sugar mill via anaerobic co-digestion: Technical and economic potential. Bioresour Technol 2020; 316:123962. [PMID: 32799048 DOI: 10.1016/j.biortech.2020.123962] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Revised: 07/31/2020] [Accepted: 08/02/2020] [Indexed: 06/11/2023]
Abstract
The main sugarcane wastes from the non-centrifugal cane sugar (NCS) agro-industry, agricultural crop residue (ACR) and sugarcane scum (SCS), were used to produce biogas in a bench-scale semi-continuous anaerobic tubular digester. A two-stage strategy was proposed to achieve the appropriate operability and stability of the digester. In the first stage, the operability of the digester was achieved with ACR mono-digestion. In the second stage, the digester feed was changed until it reached an ACR:SCS ratio (co-digestion) of 75:25, based on volatile solids, and until stability was achieved. The strategy was successful, and specific biogas production of 0.132 m3 kg-1VS with a methane content of 50.4% was achieved, confirming the technical feasibility of the process. Economic viability was established through a case study at a typical NCS mill. Therefore, anaerobic co-digestion can be consolidated as a technological alternative for the treatment of ACR + SCS and the sustainable benefit of the NCS agro-industry.
Collapse
Affiliation(s)
- O Mendieta
- Corporación Colombiana de Investigación Agropecuaria - AGROSAVIA, Centro de Investigación Tibaitatá, km 14 vía Mosquera Bogotá, Mosquera, Colombia; Grupo de Investigación en Tecnologías de Valorización de Residuos y Fuentes Agrícolas e Industriales para la Sustentabilidad Energética - INTERFASE, Escuela de Ingeniería Química, Universidad Industrial de Santander - UIS, Carrera 27, Calle 9 Ciudad Universitaria, Bucaramanga, Colombia.
| | - L Castro
- Centro de Estudios e Investigaciones Ambientales - CEIAM, Escuela de Ingeniería Química, Universidad Industrial de Santander - UIS, Carrera 27, Calle 9 Ciudad Universitaria, Bucaramanga, Colombia
| | - J Rodríguez
- Corporación Colombiana de Investigación Agropecuaria - AGROSAVIA, Centro de Investigación Tibaitatá, km 14 vía Mosquera Bogotá, Mosquera, Colombia
| | - H Escalante
- Grupo de Investigación en Tecnologías de Valorización de Residuos y Fuentes Agrícolas e Industriales para la Sustentabilidad Energética - INTERFASE, Escuela de Ingeniería Química, Universidad Industrial de Santander - UIS, Carrera 27, Calle 9 Ciudad Universitaria, Bucaramanga, Colombia
| |
Collapse
|
17
|
López Delgado A, Pérez Ferrera A, Ruiz-Tovar J, Alvarez R, Azcano E, Hevia I, Vega A, Rodríguez J, Tamargo A, Idelfonso C. How to make operating anoscopes from large syringes. Tech Coloproctol 2020; 25:479-480. [PMID: 32725354 DOI: 10.1007/s10151-020-02313-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2020] [Accepted: 07/16/2020] [Indexed: 10/23/2022]
Affiliation(s)
| | | | - J Ruiz-Tovar
- Hospital Vital Alvarez Buylla, Mieres, Asturias, Spain
| | - R Alvarez
- Hospital Vital Alvarez Buylla, Mieres, Asturias, Spain
| | - E Azcano
- Hospital Vital Alvarez Buylla, Mieres, Asturias, Spain
| | - I Hevia
- Hospital Vital Alvarez Buylla, Mieres, Asturias, Spain
| | - A Vega
- Hospital Vital Alvarez Buylla, Mieres, Asturias, Spain
| | - J Rodríguez
- Hospital Vital Alvarez Buylla, Mieres, Asturias, Spain
| | - A Tamargo
- Hospital Vital Alvarez Buylla, Mieres, Asturias, Spain
| | - C Idelfonso
- Hospital Vital Alvarez Buylla, Mieres, Asturias, Spain
| |
Collapse
|
18
|
Luque L, Rodrigo T, García-García JM, Casals M, Millet JP, Caylà J, Orcau A, Agüero R, Alcázar J, Altet N, Altube L, Álvarez F, Anibarro L, Barrón M, Bermúdez P, Bikuña E, Blanquer R, Borderías L, Bustamante A, Calpe J, Caminero J, Cañas F, Casas F, Casas X, Cases E, Castejón N, Castrodeza R, Cebrián J, Cervera A, Ciruelos J, Delgado A, De Souza M, Díaz D, Domínguez M, Fernández B, Gallardo J, Gallego M, Clemente MG, García C, García F, Garros F, Gort A, Guerediaga A, Gullón J, Hidalgo C, Iglesias M, Jiménez G, Jiménez M, Kindelan J, Laparra J, López I, Lera R, Lloret T, Marín M, Lacasa XM, Martínez E, Martínez A, Medina J, Melero C, Milà C, Millet J, Mir I, Molina F, Morales C, Morales M, Moreno A, Moreno V, Muñoz A, Muñoz C, Muñoz J, Muñoz L, Oribe M, Parra I, Penas A, Pérez J, Rivas P, Rodríguez J, Ruiz-Manzano J, Sala J, Sandel D, Sánchez M, Sánchez M, Sánchez P, Santamaría I, Sanz F, Serrano A, Somoza M, Tabernero E, Trujillo E, Valencia E, Valiño P, Vargas A, Vidal I, Vidal R, Villanueva M, Villar A, Vizcaya M, Zabaleta M, Zubillaga G. Factors Associated With Extrapulmonary Tuberculosis in Spain and Its Distribution in Immigrant Population. Open Respiratory Archives 2020. [DOI: 10.1016/j.opresp.2020.04.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
|
19
|
Farran Ortega L, Tormo Ratera M, Lluch Pons J, Mora M, Marco Pascual C, González Giménez X, Nolla JM, Rodríguez J. AB0764 SAFETY OF SYSTEMIC CORTICOSTEROIDS IN A SHORT REGIMEN IN PATIENTS WITH PSORIATIC ARTHRITIS. RETROSPECTIVE ANALYSIS OF A LARGE OBSERVATIONAL COHORT. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.5495] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:There is controversy surrounding the use of systemic corticosteroids in psoriatic arthritis (PsA). It’s an accepted fact that the use of systemic corticosteroids can trigger severe flare-up of erythroderma or pustular psoriasis. Nevertheless, corticosteroids have been used to achieve faster improvement of joint symptoms of PsA.Objectives:To analyze the use of systemic corticosteroids at intermediate doses in a short regimen in patients with PsA, as well as the serious complications of psoriasis upon withdrawal.Methods:Retrospective analysis of an observational cohort of 453 patients from a university hospital, following a specific protocol from 1992 to 2019. The following variables have been collected: corticosteroid treatment (methylprednisolone ≤16mg /day in a slow tapering regimen in 2 months), demographic and disease factors, comorbidities that could be associated (diabetes mellitus, high blood pressure, severe infections) and serious complications of psoriasis (erythroderma or pustular psoriasis). To assess the activity of psoriasis, physician global assessment is mostly used and occasionally to a lesser extent body surface area and psoriasis area severity index.Statistical analysis (SPSS v.25): descriptive analysis, Chi-squared test for qualitative variables and t-student test for quantitative variables.Results:In our series, 35.98% (163/453) of patients have received short corticosteroid regimen at some point in follow-up care, of which 93.8% received concomitant treatment with disease modifying antirheumatic drugs (DMARD).Only 6.2% of the patients who received short corticosteroid regimen presented a flare-up of psoriasis, most of them mildly. No patient developed an erythroderma or severe pustular psoriasis.After analyzing the data, a greater use of this regimen of treatment has been observed in patients with dactylitis (44.6% with dactylitis vs 27.8% without dactylitis, p<0.001) and a lower use of corticosteroids in axial PsA (14% of axial PsA vs 41% of non-axial PsA, p<0.001).There were no significant differences in the use of corticosteroids in respect to sex, age, age of onset of PsA, duration of PsA or high blood pressure. Nor in factors of poor radiographic prognosis: number of damaged joints, mutilating PsA and carpitis.Conclusion:In our series, no patient developed an erythroderma or severe pustular psoriasis and most of the flare-ups of psoriasis were mild. The use of systemic corticosteroids at intermediate doses in a slow tapering regimen concomitantly with DMARD can be safely used in patients with PsA.References:NoneDisclosure of Interests:None declared
Collapse
|
20
|
Arias de la Rosa I, López Montilla MD, Rodríguez J, Ballester E, Torres-Granados C, Perez-Sanchez C, Abalos-Aguilera MDC, Ignacio GG, Ruiz D, Patiño-Trives AM, Luque-Tévar M, Collantes-Estévez E, Lopez-Pedrera C, Escudero Contreras A, Barbarroja Puerto N. THU0003 ALTERED DNA METHYLATION AND DIFFERENTIAL EXPRESSION OF GENES INFLUENCING CARDIOVASCULAR RISK AND IMMUNITY IN CD4+ T CELLS FROM SUBJECTS WITH PSORIATIC ARTHRITIS. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.4492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Background:Cardiovascular risk factors are increased in Psoriatic Arthritis (PsA). In fact, around 60% out of PsA patients display insulin resistance (IR), a hallmark of metabolic syndrome, which might significantly contribute to the cardiovascular disease. Latest studies suggested that inflammatory and metabolic disorders may be under epigenetic control, including DNA methylation. DNA methylation is an unexplored area in the field of PsA.Objectives:To study the alterations in the genome-wide DNA methylation profile of CD4+T cells from PsA patients and its relationship with its pathology and the risk of cardiovascular comorbidity.Methods:Twenty healthy controls (HC) and 20 PsA patients were included in the study. PsA patients were classified into insulin resistant and non-insulin resistant according to HOMA-IR index. CD4+T lymphocytes were isolated from peripheral blood by positive immunomagnetic selection. The Illumina Infinium MethylationEPIC Beadchip was used to obtain DNA methylation profiles across approximately 850,000 CpGs (TSS1500, TSS200, 5UTR, 3UTR, first exon, gene body). Beta values (β) estimating methylation levels were obtained at each CpG site, and differentially methylated genes (DMG) between PsA and HC were identified. Functional classification of these genes was carried out through gene ontology analysis (PANTHER database). Gene expression analysis of the selected genes was also evaluated by RT-PCR. Vascular parameters including carotid intima-media thickness (cIMT) and endothelial function was analyzed by ecodoppler and periflux respectively.Results:The genome-wide methylation analysis identified 112 DMGs including 41 hypomethylated and 71 hypermethylated. These differentially methylated genes were enriched with several signaling pathways and disease categories including immune response, metabolic processes, oxidative stress, vascular and inflammatory pathways. The altered gene expression of selected genes with altered methylation levels in PsA was also validated. Correlation and association analysis of these DMGs with clinical and analytical variables, cardiovascular risk factors and endothelial microvascular function revealed that the degree of methylation of these genes was significantly associated with cIMT (IGF1R, NDRG3, SMYD3, HLA-DRB1, WDR70), arterial pressure (METT5D1, NRDG3, ADAM17, SMYD3, WNK1, CBX1), insulin resistance (AKAP13, SEMA6D, PLCB1), altered lipid profile and atherogenic index (MYBL1, METT5D1, MAN2A1, SLC1A7, SEMA6D, PLCB1, TLK1, SDK1, CBX1), inflammation (MYBL1, NDUFA5, METT5D1, SEMA6D, PLCB1, TLK1), and endothelial dysfunction (ADAMST10, GPCPD1, CCDC88A). In addition, this analysis also identified 435 DMGs including 280 hypomethylated and 155 hypermethylated in CD4+T cells from IR-PsA vs non IR-PsA patients. Between these two groups of PsA patients, CHUK, SERINC1, RUNX1, TTYH2, TXNDC11, FAF1, BICD1, SCD5, PDE5A, FAS, NFIA and GRP75 displayed the most significantly altered methylation, suggesting the role of these genes in the metabolic complications associated with PsA.Conclusion:These findings help our understanding of the pathogenesis of PsA and advance epigenetic studies in regards to this disease and the cardiometabolic comorbidities associated. Funded by ISCIII (PI17/01316 and RIER RD16/0012/0015) co-funded with FEDER.Disclosure of Interests:Iván Arias de la Rosa: None declared, María Dolores López Montilla Speakers bureau: Celgene, Javier Rodríguez: None declared, Esteban Ballester: None declared, Carmen Torres-Granados: None declared, Carlos Perez-Sanchez: None declared, Maria del Carmen Abalos-Aguilera: None declared, Gómez García Ignacio: None declared, Desiree Ruiz: None declared, Alejandra M. Patiño-Trives: None declared, María Luque-Tévar: None declared, Eduardo Collantes-Estévez Grant/research support from: ROCHE and Pfizer., Speakers bureau: ROCHE, Lilly, Bristol and Celgene., Chary Lopez-Pedrera Grant/research support from: ROCHE and Pfizer., Alejandro Escudero Contreras Grant/research support from: ROCHE and Pfizer, Speakers bureau: ROCHE, Lilly, Bristol and Celgene., Nuria Barbarroja Puerto Grant/research support from: ROCHE and Pfizer., Speakers bureau: ROCHE and Celgene.
Collapse
|
21
|
Perez-Sanchez C, Patiño-Trives AM, Aguirre MA, Laura PS, Luque-Tévar M, Arias de la Rosa I, Torres-Granados C, Abalos-Aguilera MDC, Seguí Azpilcueta P, Rodríguez J, Ballester E, Barbarroja Puerto N, Collantes Estevez E, Lopez-Pedrera C. THU0004 GENOME-WIDE DNA METHYLATION PROFILING IN MONOCYTES FROM PRIMARY ANTIPHOSPHOLIPID SYNDROME PATIENTS IDENTIFIES AN ABERRANT METHYLATION SIGNATURE ASSOCIATED WITH THEIR ATHEROTHROMBOTIC PHENOTYPE. Ann Rheum Dis 2020. [DOI: 10.1136/annrheumdis-2020-eular.5358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Recent studies underlined the crucial role of DNA methylation in several autoimmune diseases by altering gene expression profiles, thus influencing disease severity. Yet, aberrant methylation patterns in monocytes, key players in the pathogenesis of APS patients, has not been evaluated.Objectives:To analyze the genome-wide DNA methylation profile of monocytes from APS patients and its relationship with the cardiovascular (CV) pathology. 2. To evaluate the role of antiphospholipid antibodies (aPL) in the regulation of this process.Methods:Thirty-three APS patients and 15 healthy donors (HD) were included in the study. Monocytes were isolated from peripheral blood by positive immunomagnetic selection. The Illumina Infinium Methylation EPIC Beadchip was used to obtain DNA methylation profiles across approximately 850,000 CpGs (TSS1500, TSS200, 5UTR, 3UTR, first exon, intergenic, gene body). Beta values (β) estimating methylation levels were obtained at each CpG site, and differentially methylated genes (DMG) between APS and HD were identified. Functional classification of that genes was carried out by gene ontology analysis (PANTHER database). Gene expression of selected DMG genes was evaluated by RT-PCR. CV-risk parameters, including carotid intima-media thickness (CIMT) and microvascular endothelial function were further assessed, and correlation/association studies were developed with clinical and analytical variables. The effects of aPLs were also evaluated byin vitrostudies.Results:Genome-wide DNA methylation analysis identified 813 DMG, including 279 hypomethylated and 534 hypermethylated. Functional classification of these genes revealed signatures associated with biological processes and pathways related to their clinical profile, including immune response, adhesion, oxidative stress and vascular signaling. Correlation and association studies showed that the methylation levels of genes related to immune response were associated with the CV-risk score, aGAPSS (CCR2, TXLNB, GLIPR), type of thrombosis (SIGLEC11, COLEC11, LRRC16A, AHSA1, TRIL) and aPL titers (CLEC4G, RGS4, HLA-DPA1, GBP6, RAET1E, HLA-G, HLA-DPA1, HLA-H, TXLNB). Besides, methylation levels of DMG related to vascular signaling and adhesion processes were associated with the presence of thrombotic recurrences (VEGFA, MAPK14, ITGA8, EPCAM, PCDHA6, DLG1) as well as with traditional CV-risk factor such as hypertension and dyslipidemia (ITGA11, DSCAM, CLEC4F, CDH4, LTBP2, PCDHB14). In addition, methylation levels of DMG genes related to oxidative stress (GP2, PGD, ADH1) were associated with microvascular endothelial dysfunction. An altered mRNA expression of some of those genes with aberrant methylation and related to increased CV-risk and thrombotic recurrences in APS was also identified. Both, abnormal methylation and transcription levels of several genes were further associated with a pathological increase of the CIMT. Finally, in vitro studies supported the role of aPLs as key players in the altered methylation and transcriptomic profiles of APS patients.Conclusion:APS patients showed an impaired methylation profile in monocytes of genes associated with clinical features of the disease, including aPL titers, CV risk, thrombotic recurrences, endothelial dysfunction and early atherosclerosis. These results offered a map to the monocytes methylome and shed light on the pathophysiology of APS, paving the way for the development of new, more effective biomarkers and therapeutics.Acknowledgments:Funded by ISCIII (PI18/0837 and RIER RD16/0012/0015) co-funded with FEDER.Disclosure of Interests:Carlos Perez-Sanchez: None declared, Alejandra M. Patiño-Trives: None declared, Maria A Aguirre: None declared, Pérez Sánchez Laura: None declared, María Luque-Tévar: None declared, Iván Arias de la Rosa: None declared, Carmen Torres-Granados: None declared, Maria del Carmen Abalos-Aguilera: None declared, Pedro Seguí Azpilcueta: None declared, Javier Rodríguez: None declared, Esteban Ballester: None declared, Nuria Barbarroja Puerto Grant/research support from: ROCHE and Pfizer., Speakers bureau: ROCHE and Celgene., Eduardo Collantes Estevez Grant/research support from: ROCHE and Pfizer, Speakers bureau: ROCHE, Lilly, Bristol and Celgene, Chary Lopez-Pedrera Grant/research support from: ROCHE and Pfizer.
Collapse
|
22
|
Mendieta O, Castro L, Rodríguez J, Escalante H. Synergistic effect of sugarcane scum as an accelerant co-substrate on anaerobic co-digestion with agricultural crop residues from non-centrifugal cane sugar agribusiness sector. Bioresour Technol 2020; 303:122957. [PMID: 32058910 DOI: 10.1016/j.biortech.2020.122957] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/17/2019] [Revised: 01/29/2020] [Accepted: 02/03/2020] [Indexed: 05/25/2023]
Abstract
Anaerobic co-digestion (AcoD) of the main residues from the non-centrifugal cane sugar (NCS) making process, agricultural crop residues (ACR) and sugarcane scum (SCS), was evaluated using biochemical methane potential tests. Substrates were pretreated: ACR through particle size reduction, and SCS with dilution. The maximum methane yield of 0.276 Nm3 CH4 kg-1 VSadded occurred at an ACR of 2 mm and at 12.5% dilution of SCS, at a ratio of 75:25 based on volatile solids, which was 30.2% and 5.9% higher compared to SCS and ACR in mono-digestion, respectively. ACR was a substrate of adequate buffer capacity for the AcoD stability, while the SCS, in addition to helping accelerate the process, also helped improve the inoculum's methanogenic and hydrolytic activity. The first-order kinetic and dual-pool two-step models were suitable to describe methane yield. AcoD of ACR with SCS is a good option for the treatment of streams in the NCS agribusiness sector.
Collapse
Affiliation(s)
- O Mendieta
- Corporación Colombiana de Investigación Agropecuaria - AGROSAVIA, Centro de Investigación Tibaitatá, km 14 vía Mosquera Bogotá, Mosquera, Colombia; Grupo de Investigación en Tecnologías de Valorización de Residuos y Fuentes Agrícolas e Industriales para la Sustentabilidad Energética (INTERFASE), Escuela de Ingeniería Química, Universidad Industrial de Santander - UIS, Carrera 27, Calle 9 Ciudad Universitaria, Bucaramanga, Colombia.
| | - L Castro
- Grupo de Investigación en Tecnologías de Valorización de Residuos y Fuentes Agrícolas e Industriales para la Sustentabilidad Energética (INTERFASE), Escuela de Ingeniería Química, Universidad Industrial de Santander - UIS, Carrera 27, Calle 9 Ciudad Universitaria, Bucaramanga, Colombia
| | - J Rodríguez
- Corporación Colombiana de Investigación Agropecuaria - AGROSAVIA, Centro de Investigación Tibaitatá, km 14 vía Mosquera Bogotá, Mosquera, Colombia
| | - H Escalante
- Grupo de Investigación en Tecnologías de Valorización de Residuos y Fuentes Agrícolas e Industriales para la Sustentabilidad Energética (INTERFASE), Escuela de Ingeniería Química, Universidad Industrial de Santander - UIS, Carrera 27, Calle 9 Ciudad Universitaria, Bucaramanga, Colombia
| |
Collapse
|
23
|
Martinez-García MA, Oscullo G, Posadas T, Zaldivar E, Villa C, Dobarganes Y, Girón R, Olveira C, Maíz L, García-Clemente M, Sibila O, Golpe R, Rodríguez J, Barreiro E, Rodriguez JL, Feced-Olmos L, Prados C, Muriel A, de la Rosa D. Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis. Clin Microbiol Infect 2020; 27:428-434. [PMID: 32311472 DOI: 10.1016/j.cmi.2020.04.007] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2019] [Revised: 04/04/2020] [Accepted: 04/09/2020] [Indexed: 10/24/2022]
Abstract
OBJECTIVES The objective of this study was to analyse lung function decline over time in bronchiectasis, along with the factors associated with it. METHODS Spirometry was measured every year in this observational, prospective study in 849 patients from the Spanish Bronchiectasis Registry (RIBRON). The main outcome was the decline in the rate of forced expiratory volume during the first second (FEV1). To be included in this study, patients needed a baseline assessment and at least one subsequent assessment. FEV1 decline was analysed using a mixed-effects linear regression model adjusted for clinically significant variables. RESULTS We recruited 849 bronchiectasis patients with at least two annual lung function measurements (follow-up range 1-4 years). A total of 2262 lung function tests were performed (mean 2.66 per patient, range 2-5). Mean baseline FEV1 was 1.78 L (standard deviation (SD) 0.76; 71.3% predicted). Mean age was 69.1 (SD 15.4) years; 543 (64% women. The adjusted rates of FEV1 decline were -0.98% predicted/year (95% confidence interval (CI) -2.41 to -0.69) and -31.6 (95% CI -44.4 to -18.8) mL. The annual FEV1 decline was faster in those patients with chronic bronchial infection by Pseudomonas aeruginosa (-1.37% (52.1 mL) vs -0.37% (-24.6 mL); p < 0.001), greater age, increased number of severe exacerbations in the previous year and higher baseline FEV1 value. DISCUSSION In patients with bronchiectasis, the annual rate of FEV1 decline was -31.6 mL/year and it was faster in older patients and those with chronic bronchial infection by P. aeruginosa, increased number of previous severe exacerbations and higher baseline FEV1 value.
Collapse
Affiliation(s)
- M A Martinez-García
- Respiratory Department, Hospital Universitario y Politecnico La Fe, Valencia, Spain; CIBER de enfermedades respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
| | - G Oscullo
- Respiratory Department, Hospital Universitario y Politecnico La Fe, Valencia, Spain
| | - T Posadas
- Respiratory Department, Hospital Universitario y Politecnico La Fe, Valencia, Spain
| | - E Zaldivar
- Respiratory Department, Hospital Universitario y Politecnico La Fe, Valencia, Spain
| | - C Villa
- Respiratory Department, Clinica Fuensanta, Madrid, Spain
| | - Y Dobarganes
- Respiratory Department, Clinica Fuensanta, Madrid, Spain
| | - R Girón
- Respiratory Department, Hospital la Princesa, Madrid, Spain
| | - C Olveira
- Respiratory Department, Hospital Regional de Málaga, Málaga, Spain
| | - L Maíz
- Respiratory Department, Hospital Ramon y Cajal, Madrid, Spain
| | | | - O Sibila
- Respiratory Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain
| | - R Golpe
- Respiratory Department, Hospital Lucus Augusti, Lugo, Spain
| | - J Rodríguez
- Respiratory Department, Hospital San Agustin, Aviles, Spain
| | - E Barreiro
- Respiratory Department, Hospital del Mar, Barcelona, Spain
| | - J L Rodriguez
- Respiratory Department, Hospital San Carlos, Madrid, Spain
| | - L Feced-Olmos
- Respiratory Department, Hospital Universitario y Politecnico La Fe, Valencia, Spain
| | - C Prados
- Respiratory Department, Hospital la Paz, Madrid, Spain
| | - A Muriel
- Biostatistic Unit, Hospital Ramón y Cajal, IRYCIS, CIBERESP, Nursery Department and Physiotherapy, Alcalá University, Madrid, Spain
| | - D de la Rosa
- Respiratory Department, Hospital Plató, Barcelona, Spain
| | | |
Collapse
|
24
|
Bordes A, Campos-Herrero M, Fernández A, Vega N, Rodríguez J, Palop L. Predisposing and Prognostic Factors of Fungal Peritonitis in Peritoneal Dialysis. Perit Dial Int 2020. [DOI: 10.1177/089686089501500318] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
| | | | - A. Fernández
- Microbiology and Nephrology Services Hospital Nuestra Señora del Pino
| | - N. Vega
- Microbiology and Nephrology Services Hospital Nuestra Señora del Pino
| | - J.C. Rodríguez
- Microbiology and Nephrology Services Hospital Nuestra Señora del Pino
| | - L. Palop
- Microbiology and Nephrology Services Hospital Nuestra Señora del Pino
| |
Collapse
|
25
|
Montoya C, Rey L, Rodríguez J, Fernández MJ, Troncoso D, Cañas A, Moreno O, Henríquez B, Rojas A. Epigenetic control of the EWS‑FLI1 promoter in Ewing's sarcoma. Oncol Rep 2020; 43:1199-1207. [PMID: 32323788 PMCID: PMC7057940 DOI: 10.3892/or.2020.7489] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2019] [Accepted: 10/04/2019] [Indexed: 11/09/2022] Open
Abstract
Ewing sarcoma (ES) is a primary bone marrow tumor that very rarely develops in extra-osseous tissues, such as lung. The hallmark of ES tumors is a translocation between chromosomes 11 and 22, resulting in a fusion protein, commonly referred to as EWS-FLI1. The epigenetic profile (histone acetylation and methylation enrichment of the promoter region) that may regulate the expression of the aberrant transcription factor EWS-FLI1, remains poorly studied and understood. Knowledge of epigenetic patterns associated with covalent histone modification and expression of enzymes associated with this process, can contribute to the understanding of the molecular basis of the disease, as well as to the identification of possible molecular targets involved in expression of the EWS-FLI1 gene, so that therapeutic strategies may be improved in the future. In the present study, the transcriptional activation and repression of the EWS-FLI1 fusion gene in ES was accompanied by selective deposition of histone markers on its promoter. The EWS-FLI1 fusion gene was evaluated in two patients with ES using conventional cytogenetic, fluorescence in situ hybridization and nested PCR assays, which revealed that the aberrant expression of the EWS-FLI1 gene is accompanied by enrichment of H3K4Me3, H3K9ac and H3K27ac at the promoter region.
Collapse
Affiliation(s)
- C Montoya
- Institute of Human Genetics, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá 110231, Colombia, Chile
| | - L Rey
- Institute of Human Genetics, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá 110231, Colombia, Chile
| | - J Rodríguez
- Department of Pathology, Hospital Universitario San Ignacio, Bogotá 110231, Colombia, Chile
| | - M J Fernández
- Department of Physiological Sciences, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá 110231, Colombia, Chile
| | - D Troncoso
- Institute of Human Genetics, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá 110231, Colombia, Chile
| | - A Cañas
- Department of Internal Medicine, Hospital Universitario San Ignacio, Bogotá 110231, Colombia, Chile
| | - O Moreno
- Institute of Human Genetics, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá 110231, Colombia
| | - B Henríquez
- Faculty of Medicine and Science, Universidad San Sebastián, Santiago 7510157, Chile
| | - A Rojas
- Institute of Human Genetics, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá 110231, Colombia
| |
Collapse
|
26
|
Mendieta O, Madrigal G, Castro L, Rodríguez J, Escalante H. Sugarcane scum as a novel substrate for rapid biogas production from the non-centrifugal cane sugar agribusiness sector in developing countries. Bioresour Technol 2020; 297:122364. [PMID: 31732416 DOI: 10.1016/j.biortech.2019.122364] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/13/2019] [Revised: 10/31/2019] [Accepted: 11/01/2019] [Indexed: 06/10/2023]
Abstract
Sugarcane scum (SCS) is a waste from the non-centrifugal cane sugar making process. Due to its physicochemical characteristics, it has a high-energy potential to produce biomethane via anaerobic digestion (AD). However, (i) the total solids concentration in the SCS exceeds the limit for wet digestion and (ii) the SCS has a low pH. The aim of this research was to evaluate the utilization capacity of the SCS for methane production through a biochemical methane potential test and extent of disintegration, using dilution pretreatment. The highest methane yield, 0.227 N m3 CH4 kg-1 VS, was achieved at a 12.5% SCS dilution, with an organic matter removal greater than 70% and an extent of disintegration of 34.5%. This is evidence that the AD process is a feasible alternative for SCS treatment.
Collapse
Affiliation(s)
- O Mendieta
- Corporación Colombiana de Investigación Agropecuaria - AGROSAVIA, Centro de Investigación Tibaitatá, km 14 vía Mosquera Bogotá, Mosquera, Colombia; Grupo de Investigación en Tecnologías de Valorización de Residuos y Fuentes Agrícolas e Industriales para la Sustentabilidad Energética (INTERFASE), Escuela de Ingeniería Química, Universidad Industrial de Santander - UIS, Bucaramanga, Colombia.
| | - G Madrigal
- Grupo de investigación Ingeniería Ambiental, Universidad Peruana Unión - UPeU, Carretera Salida a Arequipa km 6 Chullunquiani, Juliaca, Peru
| | - L Castro
- Grupo de Investigación en Tecnologías de Valorización de Residuos y Fuentes Agrícolas e Industriales para la Sustentabilidad Energética (INTERFASE), Escuela de Ingeniería Química, Universidad Industrial de Santander - UIS, Bucaramanga, Colombia
| | - J Rodríguez
- Corporación Colombiana de Investigación Agropecuaria - AGROSAVIA, Centro de Investigación Tibaitatá, km 14 vía Mosquera Bogotá, Mosquera, Colombia
| | - H Escalante
- Grupo de Investigación en Tecnologías de Valorización de Residuos y Fuentes Agrícolas e Industriales para la Sustentabilidad Energética (INTERFASE), Escuela de Ingeniería Química, Universidad Industrial de Santander - UIS, Bucaramanga, Colombia
| |
Collapse
|
27
|
Azevedo C, Baeza A, Brás M, Cámara T, Cerna C, Chauveau E, Gil J, Corbacho J, Delgado V, Díaz J, Domange J, Marquet C, Macko M, Martínez-Roig M, Moreno A, Piquemal F, Rodríguez A, Rodríguez J, Roldían, C, Veloso J, Yahlali N. TRITIUM - A Quasi Real-Time Low Activity Tritium Monitor for Water. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202022503008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Tritium is released abundantly to the environment by nuclear power plants (NPP), as a product of neutron capture by hydrogen and deuterium. In normal running conditions, released cooling waters may contain levels of tritium close to or even larger than the maximum authorised limit for human consumption (drinking and irrigation). The European Council Directive 2013/51/Euratom requires a maximum level of tritium in water for human consumption lower than 100 Bq=L. Current monitoring of tritium activity in water by liquid scintillating method takes about two days and can only be carried out in a dedicated laboratory. This system is not appropriate for real time monitoring. At present, there exists no available detector device with enough sensitivity to monitor waters for human consumption with high enough sensitivity. The goal of the TRITIUM project is to build a tritium monitor capable to measure tritium activities with detection limit close to 100Bq=L, using instrumentation technique developed in recent years for Nuclear and Particle Physics, such as scintillating fibres and silicon photomultipliers (SiPM). In this paper the current status of the TRITIUM project is presented and he results of first prototypes are discussed. A detector system based on scintillating fibers read out either photomultiplier tubes (PMTs) or silicon photomultiplier (SiPM) arrays is under development and will be installed in the vicinity of Almaraz nuclear power plant (Cáceres, Spain) by the fourth term of 2019.
Collapse
|
28
|
Angón E, Castillejo L, Rodríguez J, González A, Molina D, Cueva T, García A. Fry growth modelling in Cichlasoma festae (Cichlidae) with Biobloc technology (BFT). Cienvet 2019. [DOI: 10.19137/cienvet-201921203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
29
|
Barrón F, Cardona A, Ruiz-Patiño A, Barron LZ, Corrales-Rodriguez L, Martín C, Sotelo C, Rodríguez J, Ávila J, Mayorga D, Archila P, Mas L, Freitas H, De Lima VC, Otero J, Carranza H, Vargas C, Rosell R. PD1.05 Relevance of Antibiotic Use on Clinical Activity of Immune Checkpoint Inhibitors in Hispanic Patients with Advanced Non-small-cell Lung Cancer (CLICAP-ABs). J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.09.125] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
30
|
Cardona A, Arrieta O, Ruiz-Patiño A, Barron LZ, Corrales-Rodriguez L, Martín C, Barrón F, Sotelo C, Rodríguez J, Ricaurte L, Ávila J, Mayorga D, Archila P, Otero J, Freitas H, De Lima VC, Mas L, Carranza H, Vargas C, Rosell R. PD2.06 EGFR Inhibitors + Bevacizumab Demonstrated Superior Efficacy Compared with EGFR Inhibitors Alone as First-line Treatment in Advanced NSCLC Patients with EGFR Mutations and BIM Deletion Polymorphisms. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.09.133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
31
|
Cardona A, Arrieta O, Ruiz-Patiño A, Barron LZ, Corrales-Rodriguez L, Martín C, Barrón F, Sotelo C, Rodríguez J, Ricaurte L, Freitas H, De Lima VC, Mas L, Ávila J, Mayorga D, Archila P, Otero J, Carranza H, Vargas C, Rosell R. PD2.03 Exploration of Factors Relating to Immune Response in Patients Treated with Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (NSCLC). J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.09.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
32
|
Cardona A, Arrieta O, Ruiz-Patiño A, Barron LZ, Corrales-Rodriguez L, Martín C, Barrón F, Sotelo C, Rodríguez J, Ricaurte L, Ávila J, Mayorga D, Archila P, Freitas H, De Lima VC, Mas L, Otero J, Carranza H, Vargas C, Rosell R. P2.22 Immunotherapy-related Thrombosis: Considerations and Associated Factors in Non-small Cell Lung Cancer (NSCLC) Patients. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.09.187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Mas L, Patane A, Arrieta O, Soria T, Cardona A, Martín C, Ruiz-Patiño A, Ruiz R, Rioja P, Lozano S, Barron LZ, Barrón F, Corassa M, Freitas H, De Lima VC, Corrales-Rodriguez L, Sotelo C, Rodríguez J, Ricaurte L, Ávila J, Mayorga D, Bravo M, Archila P, Otero J, Carranza H, Vargas C, Rosell R, Remon J. P1.12 Real World Characterization and Treatment Patterns of Patients with Thymic Carcinoma: Lessons from a Latin American Collaborative Study (CLICaP-LATimus). J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.09.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
34
|
Cardona A, Ruiz-Patiño A, Arrieta O, Martín C, Raez L, Barron LZ, Barrón F, Ricaurte L, Bravo-Garzón M, Mas L, Corrales-Rodriguez L, Rojas L, Lupinacci L, Perazzo F, Bas C, Carranza O, Pupareli C, Rizzo M, Mendoza RR, Rolfo C, Archila P, Rodríguez J, Sotelo C, Vargas C, Carranza H, Otero J, Pino L, Ortíz C, Laguado P, Rosell R. P2.25 Immunotherapy at Any Line of Treatment Improves Survival in Hispanic Patients with Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) Compared with Chemotherapy (Quijote-CLICaP). J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.09.190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
35
|
de Mendoza C, Roc L, Fernández‐Alonso M, Soriano V, Rodríguez C, Vera M, del Romero J, Marcaida G, Ocete M, Caballero E, Molina I, Aguilera A, Rodríguez‐Calviño J, Navarro D, Rivero C, Vilariño M, Benito R, Algarate S, Gil J, Ortiz de Lejarazu R, Rojo S, Eirós J, San Miguel A, Manzardo C, Miró J, García J, Paz I, Poveda E, Calderón E, Escudero D, Trigo M, Diz J, García‐Campello M, Rodríguez‐Iglesias M, Hernández‐Betancor A, Martín A, Ramos J, Gimeno A, Gutiérrez F, Rodríguez J, Sánchez V, Gómez‐Hernando C, Cilla G, Pérez‐Trallero E, López‐Aldeguer J, Fernández‐Pereira L, Niubó J, Hernández M, López‐Lirola A, Gómez‐Sirvent J, Force L, Cifuentes C, Pérez S, Morano L, Raya C, González‐Praetorius A, Pérez J, Peñaranda M, Hernáez‐Crespo S, Montejo J, Roc L, Martínez‐Sapiña A, Viciana I, Cabezas T, Lozano A, Fernández J, García‐Bermejo I, Gaspar G, García R, Górgolas M, Vegas C, Blas J, Miralles P, Valeiro M, Aldamiz T, Margall N, Guardia C, do Pico E, Polo I, Aguinaga A, Ezpeleta C, Sauleda S, Pirón M, González R, Barea L, Jiménez A, Blanco L, Suárez A, Rodríguez‐Avial I, Pérez‐Rivilla A, Parra P, Fernández M, Fernández‐Alonso M, Treviño A, Requena S, Benítez‐Gutiérrez L, Cuervas‐Mons V, de Mendoza C, Barreiro P, Soriano V, Corral O, Gómez‐Gallego F. HTLV testing of solid organ transplant donors. Clin Transplant 2019; 33:e13670. [DOI: 10.1111/ctr.13670] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2019] [Revised: 07/06/2019] [Accepted: 07/08/2019] [Indexed: 11/27/2022]
Affiliation(s)
- Carmen de Mendoza
- Internal Medicine Laboratory Puerta de Hierro Research Institute & University Hospital Madrid Spain
- Microbiology section, Pharmaceutical and Health Science Department Pablo-CEU University Madrid Spain
| | - Lourdes Roc
- Microbiology Department Hospital Miguel Servet Zaragoza Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Mialdun A, Bataller H, Bou-Ali MM, Braibanti M, Croccolo F, Errarte A, Ezquerro JM, Fernández JJ, Gaponenko Y, García-Fernández L, Rodríguez J, Shevtsova V. Preliminary analysis of Diffusion Coefficient Measurements in ternary mIXtures 4 (DCMIX4) experiment on board the International Space Station. Eur Phys J E Soft Matter 2019; 42:87. [PMID: 31290028 DOI: 10.1140/epje/i2019-11851-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/20/2019] [Accepted: 06/05/2019] [Indexed: 06/09/2023]
Abstract
In the frame of the Diffusion Coefficient Measurements in ternary mIXtures 4 (DCMIX4) project the thermodiffusion experiments were conducted on the International Space Station (ISS) in the Selectable Optical Diagnostics Instrument (SODI) which is on orbit since 2009. We describe the results of the preliminary analysis of images downloaded during the execution of DCMIX4 in order to check the quality of the running experiments and, if needed, adjust the experiment parameters for the following runs. The quick analysis of raw data showed that they are meaningful and will allow to obtain the transport coefficients of examined ternary and binary mixtures.
Collapse
Affiliation(s)
- A Mialdun
- MRC, CP 165/62, Université libre de Bruxelles (ULB), 50, Ave. F.D. Roosevelt, B-1050, Brussels, Belgium.
| | - H Bataller
- Laboratoire des Fluides Complexes et leurs Réservoirs, IPRA UMR5150 E2S-Université de Pau et des Pays de l'Adour (UPPA) / CNRS / TOTAL, 1, Allée du Parc Montaury, 64600, Anglet, France
| | - M M Bou-Ali
- Mechanical and Manufacturing Department, Mondragon Goi Eskola Politeknikoa (MGEP), Loramendi 4, Apdo. 23, 20500, Mondragon, Spain
| | - M Braibanti
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - F Croccolo
- Laboratoire des Fluides Complexes et leurs Réservoirs, IPRA UMR5150 E2S-Université de Pau et des Pays de l'Adour (UPPA) / CNRS / TOTAL, 1, Allée du Parc Montaury, 64600, Anglet, France
| | - A Errarte
- Mechanical and Manufacturing Department, Mondragon Goi Eskola Politeknikoa (MGEP), Loramendi 4, Apdo. 23, 20500, Mondragon, Spain
| | - J M Ezquerro
- E-USOC, Ciencias y Operaciones Aeroespaciales, Universidad Politécnica de Madrid, Madrid, Spain
| | - J J Fernández
- E-USOC, Ciencias y Operaciones Aeroespaciales, Universidad Politécnica de Madrid, Madrid, Spain
| | - Yu Gaponenko
- MRC, CP 165/62, Université libre de Bruxelles (ULB), 50, Ave. F.D. Roosevelt, B-1050, Brussels, Belgium
| | - L García-Fernández
- Laboratoire des Fluides Complexes et leurs Réservoirs, IPRA UMR5150 E2S-Université de Pau et des Pays de l'Adour (UPPA) / CNRS / TOTAL, 1, Allée du Parc Montaury, 64600, Anglet, France
- Centre National d'Études Spatiales (CNES), 2, Place Maurice Quentin, 75001, Paris, France
| | - J Rodríguez
- E-USOC, Ciencias y Operaciones Aeroespaciales, Universidad Politécnica de Madrid, Madrid, Spain
| | - V Shevtsova
- MRC, CP 165/62, Université libre de Bruxelles (ULB), 50, Ave. F.D. Roosevelt, B-1050, Brussels, Belgium
| |
Collapse
|
37
|
Braibanti M, Artola PA, Baaske P, Bataller H, Bazile JP, Bou-Ali MM, Cannell DS, Carpineti M, Cerbino R, Croccolo F, Diaz J, Donev A, Errarte A, Ezquerro JM, Frutos-Pastor A, Galand Q, Galliero G, Gaponenko Y, García-Fernández L, Gavaldá J, Giavazzi F, Giglio M, Giraudet C, Hoang H, Kufner E, Köhler W, Lapeira E, Laverón-Simavilla A, Legros JC, Lizarraga I, Lyubimova T, Mazzoni S, Melville N, Mialdun A, Minster O, Montel F, Molster FJ, Ortiz de Zárate JM, Rodríguez J, Rousseau B, Ruiz X, Ryzhkov II, Schraml M, Shevtsova V, Takacs CJ, Triller T, Van Vaerenbergh S, Vailati A, Verga A, Vermorel R, Vesovic V, Yasnou V, Xu S, Zapf D, Zhang K. European Space Agency experiments on thermodiffusion of fluid mixtures in space. Eur Phys J E Soft Matter 2019; 42:86. [PMID: 31289962 DOI: 10.1140/epje/i2019-11849-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/21/2019] [Accepted: 06/05/2019] [Indexed: 06/09/2023]
Abstract
This paper describes the European Space Agency (ESA) experiments devoted to study thermodiffusion of fluid mixtures in microgravity environment, where sedimentation and convection do not affect the mass flow induced by the Soret effect. First, the experiments performed on binary mixtures in the IVIDIL and GRADFLEX experiments are described. Then, further experiments on ternary mixtures and complex fluids performed in DCMIX and planned to be performed in the context of the NEUF-DIX project are presented. Finally, multi-component mixtures studied in the SCCO project are detailed.
Collapse
Affiliation(s)
- M Braibanti
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands.
| | - P -A Artola
- Laboratoire de Chimie-Physique, UMR 8000 CNRS, Université Paris-Sud, Orsay, France
| | - P Baaske
- Nanotemper Technologies GmbH, Munich, Germany
| | - H Bataller
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 1 Allée du Parc Montaury, 64600, Anglet, France
| | - J -P Bazile
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 64000, Pau, France
| | - M M Bou-Ali
- MGEP Mondragon GoiEskola Politeknikoa, Mechanical and Industrial Manufacturing Department, Mondragon, Spain
| | - D S Cannell
- Department of Physics, University of California at Santa Barbara, 93106, Santa Barbara, CA, USA
| | - M Carpineti
- Dipartimento di Fisica, Università degli Studi di Milano, I-20133, Milano, Italy
| | - R Cerbino
- Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, 20090, Segrate, Italy
| | - F Croccolo
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 1 Allée du Parc Montaury, 64600, Anglet, France
| | - J Diaz
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 64000, Pau, France
| | - A Donev
- Courant Institute of Mathematical Sciences, New York University, 10012, New York, NY, USA
| | - A Errarte
- MGEP Mondragon GoiEskola Politeknikoa, Mechanical and Industrial Manufacturing Department, Mondragon, Spain
| | - J M Ezquerro
- E-USOC. ETSIAE, Universidad Politécnica de Madrid, Madrid, Spain
| | - A Frutos-Pastor
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - Q Galand
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - G Galliero
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 64000, Pau, France
| | - Y Gaponenko
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - L García-Fernández
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 1 Allée du Parc Montaury, 64600, Anglet, France
- Centre National d'Etudes Spatiales (CNES), 2, Place Maurice Quentin, 75001, Paris, France
| | - J Gavaldá
- Departament de Química Física i Inòrganica, Universitat Rovira i Virgili, Tarragona, Spain
| | - F Giavazzi
- Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, 20090, Segrate, Italy
| | - M Giglio
- Dipartimento di Fisica, Università degli Studi di Milano, I-20133, Milano, Italy
| | - C Giraudet
- Erlangen Graduate School in Advanced Optical Technologies (SAOT), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany
| | - H Hoang
- Institute of Fundamental and Applied Sciences, Duy Tan University, 10C Tran Nhat Duat Street, District 1, 700000, Ho Chi Minh City, Vietnam
| | - E Kufner
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - W Köhler
- Physikalisches Institut, Universität Bayreuth, D-95440, Bayreuth, Germany
| | - E Lapeira
- MGEP Mondragon GoiEskola Politeknikoa, Mechanical and Industrial Manufacturing Department, Mondragon, Spain
| | | | - J -C Legros
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - I Lizarraga
- MGEP Mondragon GoiEskola Politeknikoa, Mechanical and Industrial Manufacturing Department, Mondragon, Spain
| | - T Lyubimova
- Institute of Continuous Media Mechanics UB RAS, 614013, Perm, Russia
| | - S Mazzoni
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
- Dipartimento di Fisica, Università degli Studi di Milano, I-20133, Milano, Italy
| | - N Melville
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - A Mialdun
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - O Minster
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - F Montel
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 64000, Pau, France
| | - F J Molster
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - J M Ortiz de Zárate
- Departamento de Estructura de la Materia, Facultad de Fisica, Universidad Complutense, Plaza de las Ciencias 1, 28040, Madrid, Spain
| | - J Rodríguez
- E-USOC. ETSIAE, Universidad Politécnica de Madrid, Madrid, Spain
| | - B Rousseau
- Laboratoire de Chimie-Physique, UMR 8000 CNRS, Université Paris-Sud, Orsay, France
| | - X Ruiz
- Centre National d'Etudes Spatiales (CNES), 2, Place Maurice Quentin, 75001, Paris, France
| | - I I Ryzhkov
- Institute of Computational Modelling SB RAS, 660036, Akademgorodok, Krasnoyarsk, Russia
| | - M Schraml
- Physikalisches Institut, Universität Bayreuth, D-95440, Bayreuth, Germany
| | - V Shevtsova
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - C J Takacs
- Department of Physics, University of California at Santa Barbara, 93106, Santa Barbara, CA, USA
| | - T Triller
- Physikalisches Institut, Universität Bayreuth, D-95440, Bayreuth, Germany
| | - S Van Vaerenbergh
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - A Vailati
- Dipartimento di Fisica, Università degli Studi di Milano, I-20133, Milano, Italy
| | - A Verga
- European Space Agency (ESA), ESTEC, Noordwijk, The Netherlands
| | - R Vermorel
- Laboratoire des Fluides Complexes et leurs Réservoirs - IPRA, UMR5150, E2S-Univ Pau & Pays Adour / CNRS / TOTAL, 64000, Pau, France
| | - V Vesovic
- Department of Earth Science and Engineering, Imperial College London, London, UK
| | - V Yasnou
- MRC, Université libre de Bruxelles, Av. F.D. Roosevelt, 50, CP165/62, 1050, Brussels, Belgium
| | - S Xu
- Key Laboratory of Microgravity, Institute of Mechanics, Chinese Academy of Science, Beijing, China
| | - D Zapf
- Physikalisches Institut, Universität Bayreuth, D-95440, Bayreuth, Germany
| | - K Zhang
- State Key Laboratory of Enhanced Oil Recovery (Research Institute of Petroleum Exploration & Development), CNPC, Beijing, China
| |
Collapse
|
38
|
Ramirez Daffos P, González-Astorga B, Jiménez E, Rubiales S, Bolaños M, Ceballos E, Rodríguez J, Reina J. Doxycycline as a preventive treatment of skin toxicity in patients with metastatic colorectal cancer treated with an anti-EGFR and chemotherapy: interim analysis to evaluate skin toxicities. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
39
|
Borrero-Palacios A, Cebrián A, Gómez Del Pulgar MT, García-Carbonero R, Garcia-Alfonso P, Aranda E, Elez E, López-López R, Cervantes A, Valladares M, Nadal C, Viéitez JM, Guillén-Ponce C, Rodríguez J, Hernández I, García JL, Vega-Bravo R, Puime-Otin A, Martínez-Useros J, Del Puerto-Nevado L, Rincón R, Rodríguez-Remírez M, Rojo F, García-Foncillas J. Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer. Sci Rep 2019; 9:7706. [PMID: 31097738 PMCID: PMC6522500 DOI: 10.1038/s41598-019-43809-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Affiliation(s)
- A Borrero-Palacios
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - A Cebrián
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain.
| | - M T Gómez Del Pulgar
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | | | - P Garcia-Alfonso
- Medical Oncology Department, Hospital Gral. Univ. Gregorio Marañón, Madrid, Spain
| | - E Aranda
- Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain
| | - E Elez
- Medical Oncology Department, Hospital Vall d'Hebrón, Barcelona, Spain
| | - R López-López
- Medical Oncology Department, Complexo Hospitalario Universitario Santiago de Compostela, Galicia, Spain
| | - A Cervantes
- Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - M Valladares
- Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, Galicia, Spain
| | - C Nadal
- Medical Oncology Department, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain
| | - J M Viéitez
- Medical Oncology Department, Hospital Universitario Central de Asturias, Asturias, Spain
| | - C Guillén-Ponce
- Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
| | - J Rodríguez
- Medical Oncology Department, Clínica Universitaria de Navarra, Navarra, Spain
| | - I Hernández
- Medical Oncology Department, Complejo Hospitalario de Navarra, Navarra, Spain
| | - J L García
- Oncology, Medical Unit, Merck S.L, an affiliate of Merck KGaA, Darmstadt, Germany
| | - R Vega-Bravo
- Anatomopathology Department, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - A Puime-Otin
- Anatomopathology Department, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - J Martínez-Useros
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - L Del Puerto-Nevado
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - R Rincón
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - M Rodríguez-Remírez
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - F Rojo
- Anatomopathology Department, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - J García-Foncillas
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain.
| |
Collapse
|
40
|
Ayrad Y, Cifuentes AL, Siguen M, Apa S, Rodríguez J, Avena N. Pierre robin sequency: importance of the palatal cleft for mandibular distraction. Int J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.ijom.2019.03.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
41
|
Ayrad Y, Rodríguez J, Avena N, Manassero G, Floria M, Apa S. Protocol for distraction osteogenesis of the medial facial third in syndromic patients. Int J Oral Maxillofac Surg 2019. [DOI: 10.1016/j.ijom.2019.03.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
42
|
Cardona AF, Rojas L, Wills B, Ruiz-Patiño A, Abril L, Hakim F, Jiménez E, Useche N, Bermúdez S, Mejía JA, Ramón JF, Carranza H, Vargas C, Otero J, Archila P, Rodríguez J, Rodríguez J, Behaine J, González D, Jacobo J, Cifuentes H, Feo O, Penagos P, Pineda D, Ricaurte L, Pino LE, Vargas C, Marquez JC, Mantilla MI, Ortiz LD, Balaña C, Rosell R, Zatarain-Barrón ZL, Arrieta O. A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma. Clin Transl Oncol 2019; 21:1364-1373. [DOI: 10.1007/s12094-019-02066-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2018] [Accepted: 02/15/2019] [Indexed: 11/30/2022]
|
43
|
Borrero-Palacios A, Cebrián A, Gómez Del Pulgar MT, García-Carbonero R, Garcia-Alfonso P, Aranda E, Elez E, López-López R, Cervantes A, Valladares M, Nadal C, Viéitez JM, Guillén-Ponce C, Rodríguez J, Hernández I, García JL, Vega-Bravo R, Puime-Otin A, Martínez-Useros J, Del Puerto-Nevado L, Rincón R, Rodríguez-Remírez M, Rojo F, García-Foncillas J. Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer. Sci Rep 2019; 9:2589. [PMID: 30796344 PMCID: PMC6385198 DOI: 10.1038/s41598-019-39291-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2018] [Accepted: 12/13/2018] [Indexed: 12/20/2022] Open
Abstract
Cetuximab is a standard-of-care treatment for RAS wild-type metastatic colorectal cancer (mCRC) but not for those harbor a KRAS mutation since MAPK pathway is constitutively activated. Nevertheless, cetuximab also exerts its effect by its immunomodulatory activity despite the presence of RAS mutation. The aim of this study was to determine the impact of polymorphism FcγRIIIa V158F and killer immunoglobulin-like receptor (KIR) genes on the outcome of mCRC patients with KRAS mutations treated with cetuximab. This multicenter Phase II clinical trial included 70 mCRC patients with KRAS mutated. We found KIR2DS4 gene was significantly associated with OS (HR 2.27; 95% CI, 1.08–4.77; P = 0.03). In non-functional receptor homozygotes the median OS was 2.6 months longer than in carriers of one copy of full receptor. Multivariate analysis confirmed KIR2DS4 as a favorable prognostic marker for OS (HR 6.71) in mCRC patients with KRAS mutation treated with cetuximab. These data support the potential therapeutic of cetuximab in KRAS mutated mCRC carrying non-functional receptor KIR2DS4 since these patients significantly prolong their OS even after heavily treatment. KIR2DS4 typing could be used as predictive marker for identifying RAS mutated patients that could benefit from combination approaches of anti-EGFR monoclonal antibodies and other immunotherapies to overcome the resistance mediated by mutation in RAS.
Collapse
Affiliation(s)
- A Borrero-Palacios
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - A Cebrián
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain.
| | - M T Gómez Del Pulgar
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | | | - P Garcia-Alfonso
- Medical Oncology Department, Hospital Gral. Univ. Gregorio Marañón, Madrid, Spain
| | - E Aranda
- Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain
| | - E Elez
- Medical Oncology Department, Hospital Vall d'Hebrón, Barcelona, Spain
| | - R López-López
- Medical Oncology Department, Complexo Hospitalario Universitario Santiago de Compostela, Galicia, Spain
| | - A Cervantes
- Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain
| | - M Valladares
- Medical Oncology Department, Complejo Hospitalario Universitario A Coruña, Galicia, Spain
| | - C Nadal
- Medical Oncology Department, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain
| | - J M Viéitez
- Medical Oncology Department, Hospital Universitario Central de Asturias, Asturias, Spain
| | - C Guillén-Ponce
- Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
| | - J Rodríguez
- Medical Oncology Department, Clínica Universitaria de Navarra, Navarra, Spain
| | - I Hernández
- Medical Oncology Department, Complejo Hospitalario de Navarra, Navarra, Spain
| | - J L García
- Oncology, Medical Unit, Merck S.L, an affiliate of Merck KGaA, Darmstadt, Germany
| | - R Vega-Bravo
- Anatomopathology Department, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - A Puime-Otin
- Anatomopathology Department, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - J Martínez-Useros
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - L Del Puerto-Nevado
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - R Rincón
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - M Rodríguez-Remírez
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - F Rojo
- Anatomopathology Department, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain
| | - J García-Foncillas
- Translational Oncology Division, Oncohealth Institute, Hospital Universitario "Fundación Jimenez Diaz", Madrid, Spain.
| |
Collapse
|
44
|
Regueira A, González-Cabaleiro R, Ofiţeru ID, Rodríguez J, Lema JM. Corrigendum to "Electron bifurcation mechanism and homoacetogenesis explain products yields in mixed culture anaerobic fermentations"[Water Res. 141(2018) 349-356]. Water Res 2018; 142:528. [PMID: 30001878 DOI: 10.1016/j.watres.2018.07.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Affiliation(s)
- A Regueira
- Dep. of Chemical Engineering, Institute of Technology, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain; School Engineering, Chemical Engineerinf, Merz Court, Newcastle Upon Tyne, NE1 7RU, United Kingdom.
| | - R González-Cabaleiro
- School Engineering, Chemical Engineerinf, Merz Court, Newcastle Upon Tyne, NE1 7RU, United Kingdom.
| | - I D Ofiţeru
- School Engineering, Chemical Engineerinf, Merz Court, Newcastle Upon Tyne, NE1 7RU, United Kingdom.
| | - J Rodríguez
- Khalifa University of Science and Technology Masdar Institute, PO Box 54244, Abu Dhabi, United Arab Emirates.
| | - J M Lema
- Dep. of Chemical Engineering, Institute of Technology, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain.
| |
Collapse
|
45
|
Regueira A, González-Cabaleiro R, Ofiţeru ID, Rodríguez J, Lema JM. Electron bifurcation mechanism and homoacetogenesis explain products yields in mixed culture anaerobic fermentations. Water Res 2018; 141:349-356. [PMID: 29804021 DOI: 10.1016/j.watres.2018.05.013] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/04/2017] [Revised: 05/09/2018] [Accepted: 05/09/2018] [Indexed: 06/08/2023]
Abstract
Anaerobic fermentation of organic wastes using microbial mixed cultures is a promising avenue to treat residues and obtain added-value products. However, the process has some important limitations that prevented so far any industrial application. One of the main issues is that we are not able to predict reliably the product spectrum (i.e. the stoichiometry of the process) because the complex microbial community behaviour is not completely understood. To address this issue, in this work we propose a new metabolic network of glucose fermentation by microbial mixed cultures that incorporates electron bifurcation and homoacetogenesis. Our methodology uses NADH balances to analyse published experimental data and evaluate the new stoichiometry proposed. Our results prove for the first time the inclusion of electron bifurcation in the metabolic network as a better description of the experimental results. Homoacetogenesis has been used to explain the discrepancies between observed and theoretically predicted yields of gaseous H2 and CO2 and it appears as the best solution among other options studied. Overall, this work supports the consideration of electron bifurcation as an important biochemical mechanism in microbial mixed cultures fermentations and underlines the importance of considering homoacetogenesis when analysing anaerobic fermentations.
Collapse
Affiliation(s)
- A Regueira
- Dep. of Chemical Engineering, Institute of Technology, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain; School of Engineering, Newcastle University, NE1 7RU, Newcastle upon Tyne, United Kingdom.
| | - R González-Cabaleiro
- School of Engineering, Newcastle University, NE1 7RU, Newcastle upon Tyne, United Kingdom; GENOCOV, Departament d'Enginyeria Química, Biològica i Ambiental, Escola d'Enginyeria, Universitat Autònoma de Barcelona, 08193, Bellaterra, Barcelona, Spain.
| | - I D Ofiţeru
- School of Engineering, Newcastle University, NE1 7RU, Newcastle upon Tyne, United Kingdom.
| | - J Rodríguez
- Khalifa University of Science and Technology Masdar Institute, PO Box 54244, Abu Dhabi, United Arab Emirates.
| | - J M Lema
- Dep. of Chemical Engineering, Institute of Technology, University of Santiago de Compostela, 15782, Santiago de Compostela, Spain.
| |
Collapse
|
46
|
Ruiz-Patiño A, Castro C, Ricaurte L, Cardona A, Rojas L, Zatarain-Barrón Z, Wills B, Reguart N, Carranza H, Vargas C, Otero J, Corrales L, Martín C, Archila P, Rodríguez J, Avila J, Bravo M, Pino L, Rosell R, Arrieta O. P02 EGFR Amplification and Sensitizing Mutations Correlates with Survival from Erlotinib in Lung Adenocarcinoma Patients. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.07.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
47
|
Rodríguez J, Villanueva H, Martínez M, Ramírez A, Téllez R, Medina I, Seijo A, Camacho A. Outcomes of HIV positive patients with Cryptococcal meningitis in the absence of optimal treatment: Experience from single institution in Mexico. Int J Infect Dis 2018. [DOI: 10.1016/j.ijid.2018.04.3965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
48
|
Algara M, López-Guerra J, Flaquer A, Beato I, Martínez F, Rodríguez J, Sanz X, Salinas J, Soler M, Frías A, Juan G, Manso A. EP-1301: Incidental or intentional node irradiation in breast cancer. preliminary results of OPTIMAL trial. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31611-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
49
|
McDonald AD, Jones BJP, Nygren DR, Adams C, Álvarez V, Azevedo CDR, Benlloch-Rodríguez JM, Borges FIGM, Botas A, Cárcel S, Carrión JV, Cebrián S, Conde CAN, Díaz J, Diesburg M, Escada J, Esteve R, Felkai R, Fernandes LMP, Ferrario P, Ferreira AL, Freitas EDC, Goldschmidt A, Gómez-Cadenas JJ, González-Díaz D, Gutiérrez RM, Guenette R, Hafidi K, Hauptman J, Henriques CAO, Hernandez AI, Hernando Morata JA, Herrero V, Johnston S, Labarga L, Laing A, Lebrun P, Liubarsky I, López-March N, Losada M, Martín-Albo J, Martínez-Lema G, Martínez A, Monrabal F, Monteiro CMB, Mora FJ, Moutinho LM, Muñoz Vidal J, Musti M, Nebot-Guinot M, Novella P, Palmeiro B, Para A, Pérez J, Querol M, Repond J, Renner J, Riordan S, Ripoll L, Rodríguez J, Rogers L, Santos FP, Dos Santos JMF, Simón A, Sofka C, Sorel M, Stiegler T, Toledo JF, Torrent J, Tsamalaidze Z, Veloso JFCA, Webb R, White JT, Yahlali N. Demonstration of Single-Barium-Ion Sensitivity for Neutrinoless Double-Beta Decay Using Single-Molecule Fluorescence Imaging. Phys Rev Lett 2018; 120:132504. [PMID: 29694208 DOI: 10.1103/physrevlett.120.132504] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2017] [Revised: 02/02/2018] [Indexed: 06/08/2023]
Abstract
A new method to tag the barium daughter in the double-beta decay of ^{136}Xe is reported. Using the technique of single molecule fluorescent imaging (SMFI), individual barium dication (Ba^{++}) resolution at a transparent scanning surface is demonstrated. A single-step photobleach confirms the single ion interpretation. Individual ions are localized with superresolution (∼2 nm), and detected with a statistical significance of 12.9σ over backgrounds. This lays the foundation for a new and potentially background-free neutrinoless double-beta decay technology, based on SMFI coupled to high pressure xenon gas time projection chambers.
Collapse
Affiliation(s)
- A D McDonald
- Department of Physics, University of Texas at Arlington, Arlington, Texas 76019, USA
| | - B J P Jones
- Department of Physics, University of Texas at Arlington, Arlington, Texas 76019, USA
| | - D R Nygren
- Department of Physics, University of Texas at Arlington, Arlington, Texas 76019, USA
| | - C Adams
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - V Álvarez
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - C D R Azevedo
- Institute of Nanostructures, Nanomodelling and Nanofabrication (i3N), Universidade de Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal
| | - J M Benlloch-Rodríguez
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - F I G M Borges
- LIP, Department of Physics, University of Coimbra, P-3004 516 Coimbra, Portugal
| | - A Botas
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - S Cárcel
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - J V Carrión
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - S Cebrián
- Laboratorio de Física Nuclear y Astropartículas, Universidad de Zaragoza, Calle Pedro Cerbuna, 12, 50009 Zaragoza, Spain
| | - C A N Conde
- LIP, Department of Physics, University of Coimbra, P-3004 516 Coimbra, Portugal
| | - J Díaz
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - M Diesburg
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Escada
- LIP, Department of Physics, University of Coimbra, P-3004 516 Coimbra, Portugal
| | - R Esteve
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - R Felkai
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - L M P Fernandes
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - P Ferrario
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - A L Ferreira
- Institute of Nanostructures, Nanomodelling and Nanofabrication (i3N), Universidade de Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal
| | - E D C Freitas
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - A Goldschmidt
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, California 94720, USA
| | - J J Gómez-Cadenas
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - D González-Díaz
- Instituto Gallego de Física de Altas Energías, Univ. de Santiago de Compostela, Campus sur, Rúa Xosé María Suárez Núñez, s/n, 15782 Santiago de Compostela, Spain
| | - R M Gutiérrez
- Centro de Investigación en Ciencias Básicas y Aplicadas, Universidad Antonio Nariño, Sede Circunvalar, Carretera 3 Este No. 47 A-15, Bogotá, Colombia
| | - R Guenette
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - K Hafidi
- Argonne National Laboratory, Argonne Illinois 60439, USA
| | - J Hauptman
- Department of Physics and Astronomy, Iowa State University, Ames, Iowa 50011-3160, USA
| | - C A O Henriques
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - A I Hernandez
- Centro de Investigación en Ciencias Básicas y Aplicadas, Universidad Antonio Nariño, Sede Circunvalar, Carretera 3 Este No. 47 A-15, Bogotá, Colombia
| | - J A Hernando Morata
- Instituto Gallego de Física de Altas Energías, Univ. de Santiago de Compostela, Campus sur, Rúa Xosé María Suárez Núñez, s/n, 15782 Santiago de Compostela, Spain
| | - V Herrero
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - S Johnston
- Argonne National Laboratory, Argonne Illinois 60439, USA
| | - L Labarga
- Departamento de Física Teórica, Universidad Autónoma de Madrid, Campus de Cantoblanco, 28049 Madrid, Spain
| | - A Laing
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - P Lebrun
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - I Liubarsky
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - N López-March
- Department of Physics, University of Texas at Arlington, Arlington, Texas 76019, USA
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - M Losada
- Centro de Investigación en Ciencias Básicas y Aplicadas, Universidad Antonio Nariño, Sede Circunvalar, Carretera 3 Este No. 47 A-15, Bogotá, Colombia
| | - J Martín-Albo
- Department of Physics, Harvard University, Cambridge, Massachusetts 02138, USA
| | - G Martínez-Lema
- Instituto Gallego de Física de Altas Energías, Univ. de Santiago de Compostela, Campus sur, Rúa Xosé María Suárez Núñez, s/n, 15782 Santiago de Compostela, Spain
| | - A Martínez
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - F Monrabal
- Department of Physics, University of Texas at Arlington, Arlington, Texas 76019, USA
| | - C M B Monteiro
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - F J Mora
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - L M Moutinho
- Institute of Nanostructures, Nanomodelling and Nanofabrication (i3N), Universidade de Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal
| | - J Muñoz Vidal
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - M Musti
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - M Nebot-Guinot
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - P Novella
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - B Palmeiro
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - A Para
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Pérez
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - M Querol
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - J Repond
- Argonne National Laboratory, Argonne Illinois 60439, USA
| | - J Renner
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - S Riordan
- Argonne National Laboratory, Argonne Illinois 60439, USA
| | - L Ripoll
- Escola Politècnica Superior, Universitat de Girona, Av. Montilivi, s/n, 17071 Girona, Spain
| | - J Rodríguez
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - L Rogers
- Department of Physics, University of Texas at Arlington, Arlington, Texas 76019, USA
| | - F P Santos
- LIP, Department of Physics, University of Coimbra, P-3004 516 Coimbra, Portugal
| | - J M F Dos Santos
- LIBPhys, Physics Department, University of Coimbra, Rua Larga, 3004-516 Coimbra, Portugal
| | - A Simón
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - C Sofka
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - M Sorel
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - T Stiegler
- Department of Physics and Astronomy, Texas A&M University, College Station, Texas 77843-4242, USA
| | - J F Toledo
- Instituto de Instrumentación para Imagen Molecular (I3M), Centro Mixto CSIC-Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain
| | - J Torrent
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| | - Z Tsamalaidze
- Joint Institute for Nuclear Research (JINR), Joliot-Curie 6, 141980 Dubna, Russia
| | - J F C A Veloso
- Institute of Nanostructures, Nanomodelling and Nanofabrication (i3N), Universidade de Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal
| | - R Webb
- Department of Physics and Astronomy, Texas A&M University, College Station, Texas 77843-4242, USA
| | - J T White
- Department of Physics and Astronomy, Texas A&M University, College Station, Texas 77843-4242, USA
| | - N Yahlali
- Instituto de Física Corpuscular (IFIC), CSIC & Universitat de València, Calle Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
| |
Collapse
|
50
|
García I, Vizoso F, Suárez C, Sanz L, Rodríguez J, Roiz C, García-Muñiz J. Relationship of Tumoral Hyaluronic Acid and Cathepsin D Contents with Histological Type of Gastric Carcinoma. Int J Biol Markers 2018. [DOI: 10.1177/172460080001500302] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The aim of this work was to evaluate the cytosolic contents of hyaluronic acid (HA) and cathepsin D (CatD) in gastric carcinomas and their possible relationships with the clinicopathological parameters of the tumors. Our study demonstrated a wide variability in the cytosolic levels of HA (mean ± SEM: 3748 ± 411 ng/mg protein) and cathepsin D (52 ± 4 pmol/mg protein) in the tumors of 78 gastric cancer patients. In addition, the tumoral contents of HA and CatD were significantly higher (p<0.005) in diffuse type (HA: 6027 ± 1099 ng/mg protein; CatD: 75 ± 13 pmol/mg protein) than in intestinal type (HA: 2735 ± 242 ng/mg protein; CatD: 42±3 pmol/mg protein) carcinomas. These data suggest that both markers may contribute to the biological characterization of gastric carcinomas.
Collapse
Affiliation(s)
- I. García
- Servicio de Cirugía General, Hospital Central de Asturias, Oviedo
| | - F. Vizoso
- Servicio de Cirugía General, Hospital de Jove, Gijón
| | - C. Suárez
- Servicio de Cirugía General, Hospital Central de Asturias, Oviedo
| | - L. Sanz
- Servicio de Cirugía General, Hospital de Jove, Gijón
| | | | - C. Roiz
- Servicio de Medicina Nuclear, Hospital Central de Asturias, Oviedo - Spain
| | | |
Collapse
|